3-(8,8-dipropyl-2-azaspiro[4.5]decan-2-yl)-N,N-diethylpropan-1-amine;dihydrochloride
-
3-(8,8-dipropyl-2-azaspiro[4.5]decan-2-yl)-N,N-diethylpropan-1-amine;dihydrochloride
structure -
-
CAS No:
130065-61-1
-
Formula:
C22H46Cl2N2
-
Chemical Name:
3-(8,8-dipropyl-2-azaspiro[4.5]decan-2-yl)-N,N-diethylpropan-1-amine;dihydrochloride
-
Synonyms:
antiprimod;atiprimod;azaspirane;N,N-diethyl-8,8-dipropyl-2-azaspiro(4.5)decane-2-propanamine dihydrochloride;SK and F 106615;SK and F 106615, dihydrochloride;SK and F-106615;SKF 106615;SKF-106615;Atiprimod dihydrochloride;130065-61-1;UNII-O12I24570R;SK&F 106615-A2;Atiprimod dihydrochloride [USAN];O12I24570R;SKF-106615-A2;2-Azaspiro(4.5)decane-2-propanamine, N,N-diethyl-8,8-dipropyl-, dihydrochloride;Atiprimod dihydrochloride (USAN);Atiprimod HCl;Atiprimod hydrochloride;SKF 1006615-A2;SCHEMBL5116678;CHEMBL3215883;DTXSID20156331;AKOS024458234;SK&F-106615-A2;SK&F-106615-I2;2-(3-(Diethylamino)propyl)-8,8-dipropyl-2-azaspiro(4.5)decane dihydrochloride;D03003;Q27285187;2-Azaspiro(4.5)decane-2-propanamine N,N-diethyl-8,8-dipropyl-, dihydrochloride;N,N-Diethyl-8,8-dipropyl-2-azaspiro[4.5]decane-2-propanamine dihydrochloride;N,N-Diethyl-8,8-dipropyl-2-azaspiro[4.5]decane-2-propanaminedihydrochloride
-
CAS No:
Description
Atiprimod Dihydrochloride is the dihydrochloride salt form of atiprimod, an orally bioavailable small molecule belonging to the azaspirane class of cationic amphiphilic agents with anti-inflammatory, antineoplastic, and anti-angiogenic activities. Atiprimod inhibits the phosphorylation of signal transducer and activator of transcription 3 (STAT3) and AKT, blocking the signaling pathways of interleukin-6, vascular endothelial growth factor (VEGF) and downregulating the anti-apoptotic proteins Bcl-2, Bcl-XL, and Mcl-1. This results in the inhibition of cell proliferation, induction of cell cycle arrest, and apoptosis.
3-(8,8-dipropyl-2-azaspiro[4.5]decan-2-yl)-N,N-diethylpropan-1-amine;dihydrochloride Basic Attributes
409.5 g/mol
408.3038049 g/mol
O12I24570R
DTXSID20156331
C76969
Request for Quotation